Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Annals of Neurology
|
May 23, 2020
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Sebastian Heinzel, Velma T E Aho, Ulrike Suenkel, et al.
NPJ Parkinson'S Disease
|
April 14, 2026
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson's disease
Andrea Mastrangelo, Isabel Wurster, Alice Ticca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 13, 2019
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile
Stefanie Lerche, Gerrit Machetanz, Isabel Wurster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 3, 2017
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles
Stefanie Lerche, Claudia Schulte, Karin Srulijes, et al.
Genomics, Proteomics & Bioinformatics
|
December 7, 2019
Machine Learning to Detect Alzheimer's Disease from Circulating Non-coding RNAs
Nicole Ludwig, Tobias Fehlmann, Fabian Kern, et al.
Frontiers in Human Neuroscience
|
June 20, 2018
Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
Daniel Stoessel, Jan-Patrick Stellmann, Anne Willing, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 28, 2020
Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease
Carlo Wilke, Marcia Cristina Teixeira Dos Santos, Claudia Schulte, et al.
Acta Neuropathologica Communications
|
October 31, 2021
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies
Kathrin Brockmann, Corinne Quadalti, Stefanie Lerche, et al.
Translational Psychiatry
|
October 9, 2019
A combined miRNA-piRNA signature to detect Alzheimer's disease
Gaurav Jain, Anne Stuendl, Pooja Rao, et al.
European Journal of Neurology
|
April 16, 2025
High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification Protocols
Stefan Bräuer, Maximilian Weber, Christian Deuschle, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Annals of Neurology
|
May 23, 2020
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Sebastian Heinzel, Velma T E Aho, Ulrike Suenkel, et al.
NPJ Parkinson'S Disease
|
April 14, 2026
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson's disease
Andrea Mastrangelo, Isabel Wurster, Alice Ticca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 13, 2019
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile
Stefanie Lerche, Gerrit Machetanz, Isabel Wurster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 3, 2017
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles
Stefanie Lerche, Claudia Schulte, Karin Srulijes, et al.
Genomics, Proteomics & Bioinformatics
|
December 7, 2019
Machine Learning to Detect Alzheimer's Disease from Circulating Non-coding RNAs
Nicole Ludwig, Tobias Fehlmann, Fabian Kern, et al.
Frontiers in Human Neuroscience
|
June 20, 2018
Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
Daniel Stoessel, Jan-Patrick Stellmann, Anne Willing, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 28, 2020
Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease
Carlo Wilke, Marcia Cristina Teixeira Dos Santos, Claudia Schulte, et al.
Acta Neuropathologica Communications
|
October 31, 2021
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies
Kathrin Brockmann, Corinne Quadalti, Stefanie Lerche, et al.
Translational Psychiatry
|
October 9, 2019
A combined miRNA-piRNA signature to detect Alzheimer's disease
Gaurav Jain, Anne Stuendl, Pooja Rao, et al.
European Journal of Neurology
|
April 16, 2025
High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification Protocols
Stefan Bräuer, Maximilian Weber, Christian Deuschle, et al.
Page
of 6